American International Group’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

American International Group’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,283	Closed	-$265K	–	3005
2024 Q1	$265K	Buy	12,283 +4,540	+59%	+$99K	﹤0.01%	1983
2023 Q4	$46.7K	Sell	7,743 -31	-0.4%	-$154	﹤0.01%	2833
2023 Q3	$43.2K	Buy	7,774 +276	+4%	+$1.78K	﹤0.01%	2850
2023 Q2	$55K	Buy	+7,498	New	+$56.8K	﹤0.01%	2857

Other funds holding LBPH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

American International Group's LBPH Position: Q2 2024 in Review

American International Group sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q2 2024, closing a stake of 12,283 shares — an estimated $265K sold.

American International Group first reported a position in LBPH in Q2 2023 and held it in 4 quarters. The position peaked at $265K in Q1 2024. 100 funds tracked by Wall St. Rank hold LBPH as of Q2 2024.

American International Group reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
American International Group sold 12,283 Longboard Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $265K.
American International Group first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
American International Group's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $265K in Q1 2024.
100 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.